Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy ...

Among treatment-naive adults living with HIV, CD4 to CD8 ratios do not differ significantly between those on dolutegravir ...

Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a ...

The product targets patients on long-term NSAID therapy who face elevated risk of gastrointestinal complications.

Sam Neill's battle with rare blood cancer AITL highlighted its symptoms, diagnosis, CAR-T therapy advances, and the ...